Strive Bitcoin Holdings Reach 25,000 Coins After $36.6 Million Purchase
Strive acquired 469 Bitcoin at an average price of $77,954, funding the buy entirely through preferred stock.
Yuna · Sep 15, 2026 · 1 min
Strive increased its Bitcoin holdings to 25,000 coins after purchasing 469 Bitcoin between Sept. 8 and Sept. 11, Decrypt reported. The Nasdaq-listed asset manager spent $36.6 million on the acquisition, paying an average of $77,954 per coin.
The company submitted an 8-K to the SEC on Sept. 14 to disclose the transaction. CEO Matt Cole stated that the purchase was funded entirely by the company's preferred stock.
“100% of the capital raised came from SATA, which now has over $1B notional outstanding,” Cole said.
During the same window, the number of SATA shares in circulation increased by 402,541, pushing the preferred stock's notional value to roughly $1.04 billion. Cash balances increased from $202.6 million to $204.2 million even after the Bitcoin purchase. Cole noted that the company's amplification ratio reached 53.5%.
“We increased amplification ratio to 53.5%,” Cole added.
The current buy marks a slowdown from the previous week, when Strive purchased 1,375 Bitcoin for about $109 million at an average price of $79,281. Class A common stock grew by only 34,206 shares during the period. Strive's stake in Strategy's STRC preferred product remained steady at 505,000 shares.
Strive currently ranks fifth among public corporate Bitcoin holders. The company holds 15 weeks to close the gap with Twenty One Capital, which controls 43,514 Bitcoin. Strive would need to buy roughly 1,234 Bitcoin per week for the remainder of 2026 to match that total.
Source: Decrypt
This story was produced by StreamSage's AI newsroom. Not financial advice.
More stories
- Sequans sells final 314 Bitcoin to end treasury strategy
The French chipmaker once held over 3,200 BTC but now reports zero crypto holdings and no outstanding debt beyond research obligations.
- Ecobank commits $2.6 billion to women and agriculture
CEO Jeremy Awori announced the plan in Lome, including a $2 billion allocation for the Ellevate by Ecobank program.
- Novo Nordisk signs $1 billion licensing deal with Nanexa
The Danish pharma major secured exclusive global rights to Nanexa's peptide delivery platform for obesity and cardiometabolic conditions.
- Best Buy cuts service transfers with AI support tools
The retailer said transfer rates dropped and more calls were resolved without a human, while development timelines for new tools shortened.